Table 1.
Anti-inflammatory properties of alternative antidepressant treatments.
Drug Classification | Mood/Affect | Inflammation | Sources |
---|---|---|---|
Ketamine/NMDA receptor antagonists | - rapid onset (30 min) of antidepressant effects, especially in treatment resistant depression - decreased rumination, depressive behaviors, and depression scores - Antidepressant effects persist for up to 7 days |
- Decreased pro-inflammatory cytokines (i.e., TNF-α) that are correlated with decreased depression | Human
|
Cannabis/Cannabinoid | - THC, CBD, and HU-580 show antidepressant-like effects in rodent behavioral tests - UCS decreases eCB signalling - FAAH enzyme inhibition leads to anti-depressant effects |
- Decreased inflammatory cytokines (e.g., IL-6, TNF-α, IFN-ß) - Decreased PGE2, COX activity, oxygen-derived free radicals, and nitric oxide - Chronic stress induces inflammation which is rescued by cannabinoid treatment |
HumanAnimal |
Psychedelics | - Decreased stress and anxiety-related behaviors - Rapid and long-term antidepressant effects in MDD lasting up to 6 months |
- Decreased CRP that correlates with decreased depression - 5-MeO-DsMT increased cortisol and decreased IL-6 |
Human
|
Note: Acronyms: UCS – unpredictable chronic stress, eCB – endocannabinoids, FAAH - Fatty acid amide hydrolase, TNF-α - Tumor necrosis factor alpha, IFN-ß – Tumor necrosis factor beta, PGE2 - Prostaglandin E2, COX – cyclooxygenase, CRP – C-reactive protein, 5-MeO-DMT - 5-methoxy-N,N-dimethyltryptamine, IL-6 – Interleukin-6, HU-580 – cannabidiolic acid methyl ester, MDD – major depressive disorder.